SARTORIUS AG VZO O.N. chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 58.98
Dividend & Yield1.26€ (0.35%)
Beta 0.67
Market capitalization 22.27B
Operating cash flow 676.81M
ESG Scores unknown

Company description

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial Ratios
Quick Ratio0.58
Working Capital1.28
Return On Equity0.25
Debt To Equity1.31
Fixed Asset Ratio0.22
Fixed Interest Cover35.12

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities
Total Cashflows From Investing Activities -242.48M -268.68M -1.27B -569.61M
Net Borrowings 49.62M -12.58M 989.15M -74.71M
Total Cash From Financing Activities -16.7M -101.55M 907.47M -165.18M
Change To Operating Activities 52.8M 36.6M 166.63M 311.33M
Issuance Of Stock
Net Income 141.34M 156.69M 210.09M 318.89M
Change In Cash -14.26M 9.28M 148.99M 139.37M
Effect Of Exchange Rate 400k -157k 539k 8.01M
Total Cash From Operating Activities 244.52M 377.19M 511.52M 865.81M
Depreciation 104.87M 129.72M 157.53M 205.96M
Change To Account Receivables -44.66M 18.17M -59.26M -99.14M
Other Cashflows From Financing Activities -31.78M -46.91M -57.4M -42.24M
Change To Netincome 63.87M 113.11M 128.13M 397.98M
Capital Expenditures -233.18M -225.57M -240.25M -407.17M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 78.2M 95.59M 108.42M 139.88M
Income Before Tax 270.69M 302.99M 424.75M 668.42M
Net Income 141.34M 156.69M 210.09M 318.89M
Selling General Administrative 425.19M 478.23M 565.25M 746.07M
Gross Profit 803.6M 941.1M 1.21B 1.84B
Ebit 299.5M 362.09M 510.73M 932.99M
Operating Income 299.5M 362.09M 510.73M 932.99M
Interest Expense -13.39M -14.69M -21.68M -26.57M
Income Tax Expense 73.22M 84.39M 125.19M 241.44M
Total Revenue 1.57B 1.83B 2.34B 3.45B
Cost Of Revenue 762.43M 885.87M 1.13B 1.61B
Total Other Income ExpenseNet -28.8M -59.1M -85.98M -264.56M
Net Income From Continuing Ops 197.48M 218.6M 299.56M 426.98M
Net Income Applicable To Common Shares 141.34M 156.69M 210.09M 318.89M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 1.55B 1.78B 3.1B 3.98B
Total Stockholder Equity 740.57M 810.35M 1.03B 1.26B
Other Current Liabilities 162.56M 238.85M 353.45M 718.32M
Total Assets 2.53B 2.87B 4.48B 5.7B
Common Stock 68.39M 68.39M 68.42M 68.42M
Other Current Assets 38.46M 45.3M 92.18M 84.79M
Retained Earnings 639.81M 710.04M 997.27M 1.17B
Treasury Stock 32.37M 31.92M -34.25M 25.86M
Cash 45.16M 54.44M 203.44M 342.81M
Total Current Liabilities 480.7M 662.61M 871.09M 1.55B
Other Stockholder Equity 32.37M 31.92M -34.25M 25.86M
Property, Plant, and Equipment 411.46M 723.44M 803.72M 986.03M
Total Current Assets 753.95M 851.01M 1.21B 1.8B
Net Tangible Assets -233.93M -202.44M -1.06B -1.03B
Net Receivables 326.45M 326.16M 342.2M 458.2M
Accounts Payable 120.47M 141.15M 189.81M 283M


Insider Transactions

Here are the insider transactions of stock shares related to SARTORIUS AG VZO O.N.:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to SARTORIUS AG VZO O.N.. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on SARTORIUS AG VZO O.N.

Here is the result of two systematic investment strategies applied to SARTORIUS AG VZO O.N.. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on SARTORIUS AG VZO O.N.

The following chart shows the equity curve of the two systematic investment strategies applied to SARTORIUS AG VZO O.N.:

SARTORIUS AG VZO O.N. automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 109.5% on the backtest period.

Performance at glance

Performance

109.5 %

Latent gain

2248.7 €

Invested capital

2053.7 €

Annualized return

26.58 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on SARTORIUS AG VZO O.N.

This is the result of two momentum investment strategies applied to SARTORIUS AG VZO O.N.. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on SARTORIUS AG VZO O.N.

The following chart shows all the entries opened by the momentum investment system on SARTORIUS AG VZO O.N.:

SARTORIUS AG VZO O.N. momentum entries
  • The first momentum investment strategy would give 125.04% of return on SARTORIUS AG VZO O.N.. That represents 6872.9€ of latent gain with 5496.5€ of employed capital.
  • The second momentum investment strategy would give 135.74% of return on SARTORIUS AG VZO O.N.. That represents 4335.4€ of latent gain with 3193.8€ of employed capital.
Performance at glance (1Q Momentum)

Performance

125.04 %

Latent gain

6872.9 €

Invested capital

5496.5 €

Annualized return

22.99 %
Performance at glance (2Q Momentum)

Performance

135.74 %

Latent gain

4335.4 €

Invested capital

3193.8 €

Annualized return

37.29 %

Momentum equity curve on SARTORIUS AG VZO O.N.

The following chart shows the equity curve of the two momentum strategies applied to SARTORIUS AG VZO O.N.:

SARTORIUS AG VZO O.N. momentum equity

Note: the dividends potentially given by SARTORIUS AG VZO O.N. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SARTORIUS AG VZO O.N.

The following chart shows the employed capital evolution of the two momentum strategies on SARTORIUS AG VZO O.N. since the beginning:

SARTORIUS AG VZO O.N.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on SARTORIUS AG VZO O.N.

Buy the dip entry openings on SARTORIUS AG VZO O.N.

SARTORIUS AG VZO O.N.

The performance achieved by the robo-advisor on SARTORIUS AG VZO O.N. is 48.73%. That represents 1585.9$ of latent gain with 3254.3€ of employed capital. The following chart shows SARTORIUS AG VZO O.N. stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of SARTORIUS AG VZO O.N., and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

48.73 %

Latent gain

1585.9 €

Invested capital

3254.3 €

Annualized return

22.99 %

Equity curve of the strategy applied to SARTORIUS AG VZO O.N.

The following chart shows the result of the investment strategy applied to SARTORIUS AG VZO O.N.:

SARTORIUS AG VZO O.N.

Note: the dividends potentially given by SARTORIUS AG VZO O.N. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SARTORIUS AG VZO O.N.

The following chart shows the employed capital evolution since the beginning of the investment strategy on SARTORIUS AG VZO O.N.:

SARTORIUS AG VZO O.N.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on SARTORIUS AG VZO O.N.

In this section, I will compare the three previous investment strategies applied to SARTORIUS AG VZO O.N..

Equity curve comparison on SARTORIUS AG VZO O.N.

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

SARTORIUS AG VZO O.N. investment strategy comparison

Employed capital comparison on SARTORIUS AG VZO O.N.

SARTORIUS AG VZO O.N. investment comparison

Performance comparison on SARTORIUS AG VZO O.N.

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 109.5% 2248.7€ 2053.7€ 26.58%
Momentum 1 quarter 125.04% 6872.9€ 5496.5€ 32.23%
Momentum 2 quarters 135.74% 4335.4€ 3193.8€ 37.29%
Non-directional 48.73% 1585.9€ 3254.3€ 22.99%
Annualized return comparison

Automatic investment

26.58 %

Momentum 1Q

37.29 %

Momentum 2Q

37.29 %

Non-directional

22.99 %

Correlated stocks

Here are the most positively and negatively correlated stocks with SARTORIUS AG VZO O.N.:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between SARTORIUS AG VZO O.N. and the other stocks. There may be false positives or some missing correlated stocks. If the price of SARTORIUS AG VZO O.N. does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name SARTORIUS AG VZO O.N.
Country Germany
City Göttingen
Address Otto-Brenner-Strasse 20
Phone 49 551 308 0
Website www.sartorius.com
FullTime employees 16038
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XETRA
Ticker SRT3.XETRA
Market www.xetra.com

SARTORIUS AG VZO O.N. ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown